Dr Sachin Gawde is a nuclear medicine and PET-CT specialist at HCG Cancer Centre, Mumbai with more than 10 years of experience in reporting diagnostic nuclear medicine investigations, PET-CT scans and administering high dose radioisotope therapies.
His expertise lies in PET CT imaging with a special interest in oncology imaging and administering high dose radioisotope therapies (toxic radioiodine therapy for hyperthyroidism, radioiodine therapy for thyroid cancer, bone pain palliation for osteoblastic skeletal metastases, radiation synovectomy for inflamed joints, Lutetium- PSMA therapy for prostate cancer and Lutetium DOTATATE/ DOTANOC therapy for neuroendocrine tumours).
He has experience of reporting more than 20000 PET-CT scans, which include contrast-enhanced PET-CT (Whole Body FDG PET-CT, limited area (Regional) FDG PET-CT, infection imaging, whole-body fluoride bone scan, whole body 68Ga-DOTA and 68Ga-PSMA PET scan, fluorothymidine (FLT) brain PET, FDG brain PET and cardiac viability PET imaging).
He also has vast experience in reporting diagnostic nuclear medicine investigations (e.g., bone, renal, hepatobiliary, myocardial perfusion, hynic-toc, thyroid, iodine scans, etc.).
He has multiple national and international publications to his credit. He has also presented papers at various conferences.
Case of Solitary Peritoneal Metastasis From Atypical Bronchopulmonary Carcinoid on 18F-FDG PET/CT. Clin Nucl Med. 2019 Mar;44(3):e154-e157.
Utility of negative oral contrast (milk with 4% fat) in PET-CT studies. Indian J Nucl Med. 2012 Jul;27(3):151-5.
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.